Biopharmaceutical Contract Manufacturing Study Finds Industry Growth Over the Past Two Years and Expects to Continue Its Growth Trajectory.SAN JOSE San Jose, city, United States San Jose (sănəzā`, săn hōzā`), city (1990 pop. 782,248), seat of Santa Clara co., W central Calif.; founded 1777, inc. 1850. , Calif. -- The demand for biopharmaceutical contract manufacturing services is expected to grow at 16% annually over the next 5 years as biopharmaceutical business models shift toward more outsourcing (1) Contracting with outside consultants, software houses or service bureaus to perform systems analysis, programming and datacenter operations. Contrast with insourcing. See netsourcing, ASP, SSP and facilities management. of production requirements, as well as some large pharmaceutical companies choosing not to expand their internal capacities. Industry expression yields have improved significantly, and new technologies such as better expression systems, more efficient cell lines and improved media present new opportunities to improve productivity further. The ninth industry study published by HighTech Business Decisions "Biopharmaceutical Contract Manufacturing 2009: Expanding Markets, New Capacities and Improved Performance" reports that current contractor capacity utilization Capacity Utilization measures the rate at which a firm makes use of their capital productive capacities, such as factories and machinery. Capacity Utilization generally rises when the economy is healthy and falls when demand softens. is slightly lower than 2006 levels. This temporary decline in utilization results from a combination of previous investment in capacity, improved expression yields, and slow down in biotechnology investments because of the current financial markets. Over the next few years, demand is expected to grow as new biopharmaceuticals move through the clinical pipeline and become commercial products. William Downey, president of HighTech Business Decisions, explains, "We extensively interviewed 48 biomanufacturing and outsourcing directors of biopharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. worldwide, and 29 biopharmaceutical contract manufacturers ("CMOs"). There is general consensus that the CMO CMO See: Collateralized mortgage obligation CMO See collateralized mortgage obligation (CMO). industry as a whole will remain strong and grow, but the industry will undergo consolidations." The market for biopharmaceutical contract manufacturing is estimated to be US$2.6B in 2009, and long-term Long-term Three or more years. In the context of accounting, more than 1 year. long-term 1. Of or relating to a gain or loss in the value of a security that has been held over a specific length of time. Compare short-term. growth prospects remain strong through 2014. This 900-page report with 290 summary data tables and charts provide in-depth analysis of the dynamic factors impacting the industry, including new equipment and disposable disposable Nursing adjective Referring to that which is discarded or disposed of noun An item used in health care-related Pt contact which is discarded after use–eg masks, gloves, gowns, needles, paper products, syringes, wipes. See Biohazardous waste. technologies, improved expression levels, increasing competitiveness, changing outsourcing strategies, capacity forecasts, changes in outsourcing spending and margins, and biomanufacturing in low-cost regions. About HighTech Business Decisions HighTech Business Decisions is a market research and consulting firm Noun 1. consulting firm - a firm of experts providing professional advice to an organization for a fee consulting company business firm, firm, house - the members of a business organization that owns or operates one or more establishments; "he worked for a specializing in the areas of pharmaceutical drug discovery and biopharmaceutical contract manufacturing. The company has been producing in-depth public reports and customized benchmarking, market analysis and customer loyalty programs for over ten years. Visit us at www.HighTechDecisions.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion